Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Foreword: 4th edition of the American Society of Transplantation Infectious Diseases Guidelines.

Green M, Blumberg EA, Danziger-Isakov L, Huprikar S, Kotton CN, Kumar D.

Clin Transplant. 2019 Jun 19:e13642. doi: 10.1111/ctr.13642. [Epub ahead of print] No abstract available.

PMID:
31216079
2.

#Less Is More: Now Trending for Surgical Antibacterial Prophylaxis in Liver Transplantation.

Hand J, Huprikar S.

Liver Transpl. 2019 Jul;25(7):993-994. doi: 10.1002/lt.25491. No abstract available.

PMID:
31081990
3.

Vancomycin-resistant Enterococcus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.

Nellore A, Huprikar S; AST ID Community of Practice.

Clin Transplant. 2019 Mar 26:e13549. doi: 10.1111/ctr.13549. [Epub ahead of print]

PMID:
30913322
4.

Higher rates of rejection in HIV-infected kidney transplant recipients on ritonavir-boosted protease inhibitors: 3-year follow-up study.

Rollins B, Farouk S, DeBoccardo G, Lerner S, Rana M, Huprikar S, Miko L, Delaney V, Florman S, Shapiro R.

Clin Transplant. 2019 Jun;33(6):e13534. doi: 10.1111/ctr.13534. Epub 2019 Apr 3.

PMID:
30864166
5.

Adherence to fluid resuscitation guidelines and outcomes in patients with septic shock: Reassessing the "one-size-fits-all" approach.

Truong TN, Dunn AS, McCardle K, Glasser A, Huprikar S, Poor H, Raucher B, Poeran J.

J Crit Care. 2019 Jun;51:94-98. doi: 10.1016/j.jcrc.2019.02.006. Epub 2019 Feb 5.

PMID:
30784983
6.

Marijuana use in transplantation: A call for clarity.

Levi ME, Montague BT, Thurstone C, Kumar D, Huprikar SS, Kotton CN; Executive Committee of the Infectious Diseases Community of Practice of the American Society of Transplantation.

Clin Transplant. 2019 Feb;33(2):e13456. doi: 10.1111/ctr.13456. Epub 2019 Jan 22. Review.

PMID:
30506888
7.

An electronic antimicrobial stewardship intervention reduces inappropriate parenteral antibiotic therapy.

Liu STH, Bailey MJ, Zheng A, Saunders-Hao P, Bassily-Marcus A, Harding M, Rana M, Kohli-Seth R, Patel G, Huprikar S, Swartz TH.

Infect Control Hosp Epidemiol. 2018 Nov;39(11):1396-1397. doi: 10.1017/ice.2018.220. Epub 2018 Sep 20. No abstract available.

PMID:
30231950
8.

Organs from deceased donors with false-positive HIV screening tests: An unexpected benefit of the HOPE act.

Durand CM, Halpern SE, Bowring MG, Bismut GA, Kusemiju OT, Doby B, Fernandez RE, Kirby CS, Ostrander D, Stock PG, Mehta S, Turgeon NA, Wojciechowski D, Huprikar S, Florman S, Ottmann S, Desai NM, Cameron A, Massie AB, Tobian AAR, Redd AD, Segev DL.

Am J Transplant. 2018 Oct;18(10):2579-2586. doi: 10.1111/ajt.14993. Epub 2018 Jul 23.

PMID:
29947471
9.

Training in transplant infectious diseases: A survey of infectious diseases and transplant infectious diseases fellows in the United States and Canada.

Tan SK, Theodoropoulos N, La Hoz RM, Mossad SB, Kotton CN, Danziger-Isakov LA, Kumar D, Huprikar S; American Society of Transplantation, Infectious Diseases Community of Practice.

Transpl Infect Dis. 2018 Aug;20(4):e12915. doi: 10.1111/tid.12915. Epub 2018 Jun 13.

PMID:
29797612
10.

The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation.

Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L, Humar A; The Transplantation Society International CMV Consensus Group.

Transplantation. 2018 Jun;102(6):900-931. doi: 10.1097/TP.0000000000002191. Review.

PMID:
29596116
11.

Central nervous system histoplasmosis: Multicenter retrospective study on clinical features, diagnostic approach and outcome of treatment.

Wheat J, Myint T, Guo Y, Kemmer P, Hage C, Terry C, Azar MM, Riddell J, Ender P, Chen S, Shehab K, Cleveland K, Esguerra E, Johnson J, Wright P, Douglas V, Vergidis P, Ooi W, Baddley J, Bamberger D, Khairy R, Vikram HR, Jenny-Avital E, Sivasubramanian G, Bowlware K, Pahud B, Sarria J, Tsai T, Assi M, Mocherla S, Prakash V, Allen D, Passaretti C, Huprikar S, Anderson A.

Medicine (Baltimore). 2018 Mar;97(13):e0245. doi: 10.1097/MD.0000000000010245. Erratum in: Medicine (Baltimore). 2018 Apr;97(16):e0537.

12.

Organ donor screening practices for Strongyloides stercoralis infection among US organ procurement organizations.

Abanyie FA, Valice E, Delli Carpini KW, Gray EB, McAuliffe I, Chin-Hong PV, Handali S, Montgomery SP, Huprikar S.

Transpl Infect Dis. 2018 Jun;20(3):e12865. doi: 10.1111/tid.12865. Epub 2018 Mar 31.

13.

Low-dose valganciclovir for cytomegalovirus prophylaxis in intermediate-risk liver transplantation recipients.

Khan S, Sullivan T, Ali M, Dunn D, Patel G, Huprikar S.

Liver Transpl. 2018 May;24(5):616-622. doi: 10.1002/lt.25047.

14.

Recommendations for Management of Endemic Diseases and Travel Medicine in Solid-Organ Transplant Recipients and Donors: Latin America.

Clemente WT, Pierrotti LC, Abdala E, Morris MI, Azevedo LS, López-Vélez R, Cuenca-Estrella M, Torre-Cisneros J, Petersen E, Camargo LFA, Wright AJ, Beeching NJ, Vilela EG, Santoro-Lopes G, Len O, Stucchi RSB, Manuel O, Faria LC, Leblebicioglu H, Huprikar S, Molina I, Mourão PHO, Kotton CN, Aguado JM; working group on Endemic Disease and Travel Medicine in Solid-Organ Transplantation.

Transplantation. 2018 Feb;102(2):193-208. doi: 10.1097/TP.0000000000002027. Review. Erratum in: Transplantation. 2019 Jan;103(1):e38. Rabagliatti, Ricardo [corrected to Rabagliati, Ricardo].

PMID:
29381647
15.

Viral Hepatitis Recommendations for Solid-Organ Transplant Recipients and Donors.

Faria LC, Terrabuio DRB, Leblebicioglu H, Huprikar S.

Transplantation. 2018 Feb;102(2S Suppl 2):S66-S71. doi: 10.1097/TP.0000000000002013. Review. No abstract available.

PMID:
29381580
16.

Tuberculosis after liver transplantation in a large center in New York City: QuantiFERON® -TB Gold-based pre-transplant screening performance and active tuberculosis post-transplant.

Hand J, Sigel K, Huprikar S, Hamula C, Rana M.

Transpl Infect Dis. 2018 Apr;20(2):e12845. doi: 10.1111/tid.12845. Epub 2018 Feb 19.

PMID:
29359834
17.

Successful heart transplantation in patients with active Staphylococcus bloodstream infection and suspected mechanical circulatory support device infection.

Sullivan T, Taimur S, Rana M, Patel G, Pinney S, Anyanwu A, Huprikar S.

Transpl Infect Dis. 2018 Feb;20(1). doi: 10.1111/tid.12812. Epub 2017 Dec 21.

PMID:
29139180
18.

Successful heart transplantation in patients with total artificial heart infections.

Taimur S, Sullivan T, Rana M, Patel G, Roldan J, Ashley K, Pinney S, Anyanwu A, Huprikar S.

Transpl Infect Dis. 2018 Feb;20(1). doi: 10.1111/tid.12801. Epub 2017 Dec 21. Review.

PMID:
29110413
19.

Estimating Local Costs Associated With Clostridium difficile Infection Using Machine Learning and Electronic Medical Records.

Pak TR, Chacko KI, O'Donnell T, Huprikar SS, van Bakel H, Kasarskis A, Scott ER.

Infect Control Hosp Epidemiol. 2017 Dec;38(12):1478-1486. doi: 10.1017/ice.2017.214. Epub 2017 Nov 6.

20.

Low-dose valganciclovir prophylaxis for cytomegalovirus in intermediate-risk (R+) renal transplant recipients: Single-center experience.

Khan S, Fischman C, Huprikar S.

Transpl Infect Dis. 2017 Dec;19(6). doi: 10.1111/tid.12780. Epub 2017 Nov 3.

PMID:
28940831
21.

An ISHLT consensus document for prevention and management strategies for mechanical circulatory support infection.

Kusne S, Mooney M, Danziger-Isakov L, Kaan A, Lund LH, Lyster H, Wieselthaler G, Aslam S, Cagliostro B, Chen J, Combs P, Cochrane A, Conway J, Cowger J, Frigerio M, Gellatly R, Grossi P, Gustafsson F, Hannan M, Lorts A, Martin S, Pinney S, Silveira FP, Schubert S, Schueler S, Strueber M, Uriel N, Wrightson N, Zabner R, Huprikar S.

J Heart Lung Transplant. 2017 Oct;36(10):1137-1153. doi: 10.1016/j.healun.2017.06.007. Epub 2017 Jun 23. Review. No abstract available.

PMID:
28781010
22.

Elevated Serum Beta-D-Glucan with Pseudomonas, Aspergillus, and a Partially Acid-Fast Organism in Respiratory Cultures: A Case of Hickam's Dictum Over Occam's Razor.

Khan S, Hamula C, Rana M, Sullivan T, Dunn D, Patel P, Mishkin A, Huprikar S.

Mycopathologia. 2017 Oct;182(9-10):869-872. doi: 10.1007/s11046-017-0157-1. Epub 2017 Jun 16.

PMID:
28623531
23.

Genomic confirmation of vancomycin-resistant Enterococcus transmission from deceased donor to liver transplant recipient.

Bashir A, Attie O, Sullivan M, Sebra R, Singh KV, Altman D, Pak T, Dutta J, Chacko K, Webster E, Lewis M, Hamula C, Delli Carpini KW, Murray BE, Kasarskis A, van Bakel H, Huprikar S.

PLoS One. 2017 Mar 16;12(3):e0170449. doi: 10.1371/journal.pone.0170449. eCollection 2017.

24.

Early conversion to belatacept after renal transplantation.

Nair V, Liriano-Ward L, Kent R, Huprikar S, Rana M, Florman SS, Delaney VB, Menon MC, Sehgal V, Miko L, Khaim R, Benvenisty A, Lerner S, Arvelakis A, Wadhera V, Ames S, Shapiro R.

Clin Transplant. 2017 May;31(5). doi: 10.1111/ctr.12951. Epub 2017 Apr 19.

PMID:
28267882
25.

Transplant Infectious Diseases: A Review of the Scientific Registry of Transplant Recipients Published Data.

Kotton CN, Huprikar S, Kumar D.

Am J Transplant. 2017 Jun;17(6):1439-1446. doi: 10.1111/ajt.14195. Epub 2017 Feb 23. Review.

26.

Belatacept Conversion in an HIV-Positive Kidney Transplant Recipient With Prolonged Delayed Graft Function.

Ebcioglu Z, Liu C, Shapiro R, Rana M, Salem F, Florman S, Huprikar S, Nair V.

Am J Transplant. 2016 Nov;16(11):3278-3281. doi: 10.1111/ajt.13923. Epub 2016 Jul 18.

27.

Trainee Needs in Pediatric Transplant Infectious Diseases Education.

Ganapathi L, Danziger-Isakov L, Kotton C, Kumar D, Huprikar S, Michaels MG, Englund JA.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):301-304. doi: 10.1093/jpids/piw062.

PMID:
27760798
28.

A Real-World Evaluation of Repeat Paracentesis-guided Management of Spontaneous Bacterial Peritonitis.

Goel A, Biewald M, Huprikar S, Schiano T, Im GY.

J Clin Gastroenterol. 2017 Mar;51(3):278-284. doi: 10.1097/MCG.0000000000000704.

PMID:
27661968
29.

Unique characteristics of cryptococcosis identified after death in patients with liver cirrhosis: comparison with concurrent cohort diagnosed antemortem.

Singh N, Sifri CD, Silveira FP, Miller R, Gregg KS, Huprikar S, Lease ED, Zimmer A, Dummer JS, Spak CW, Koval C, Banach DB, Shroff M, Le J, Ostrander D, Avery R, Eid A, Razonable RR, Montero J, Blumberg E, Alynbiawi A, Morris MI, Randall HB, Alangaden G, Tessier J, Cacciarelli TV, Wagener MM, Sun HY.

Med Mycol. 2017 Apr 1;55(3):278-284. doi: 10.1093/mmy/myw079.

PMID:
27601609
30.

Getting to zero: Reduction in the incidence of multidrug-resistant organism infections using an integrated infection control protocol in an intensive care unit.

Gupta R, Hannon E, Huprikar S, Bassily-Marcus A, Manasia A, Oropello J, Kohli-Seth R.

Am J Infect Control. 2016 Dec 1;44(12):1695-1697. doi: 10.1016/j.ajic.2016.07.003. Epub 2016 Aug 26.

PMID:
27575774
31.

The Epidemiology and Clinical Features of Clostridium difficile Infection in Liver Transplant Recipients.

Sullivan T, Weinberg A, Rana M, Patel G, Huprikar S.

Transplantation. 2016 Sep;100(9):1939-43. doi: 10.1097/TP.0000000000001309.

PMID:
27379554
32.

Outcomes of spontaneous bacterial peritonitis in liver transplant recipients with allograft failure.

Leong J, Huprikar S, Schiano T.

Transpl Infect Dis. 2016 Aug;18(4):545-51. doi: 10.1111/tid.12565.

PMID:
27261101
33.

Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls.

Roland ME, Barin B, Huprikar S, Murphy B, Hanto DW, Blumberg E, Olthoff K, Simon D, Hardy WD, Beatty G, Stock PG; HIVTR Study Team.

AIDS. 2016 Jan 28;30(3):435-44. doi: 10.1097/QAD.0000000000000934.

34.

Reply to: "need to consider full societal impact of hepatitis B virus-positive donors".

Huprikar S, Danziger-Isakov L, Ahn J, Kotton CN, Kumar D.

Am J Transplant. 2015 Nov;15(11):3014. doi: 10.1111/ajt.13451. Epub 2015 Sep 15. No abstract available.

35.

Whole-genome sequencing identifies emergence of a quinolone resistance mutation in a case of Stenotrophomonas maltophilia bacteremia.

Pak TR, Altman DR, Attie O, Sebra R, Hamula CL, Lewis M, Deikus G, Newman LC, Fang G, Hand J, Patel G, Wallach F, Schadt EE, Huprikar S, van Bakel H, Kasarskis A, Bashir A.

Antimicrob Agents Chemother. 2015 Nov;59(11):7117-20. doi: 10.1128/AAC.01723-15. Epub 2015 Aug 31.

36.

Low adherence of HIV providers to practice guidelines for hepatocellular carcinoma screening in HIV/hepatitis B coinfection.

Hearn B, Chasan R, Bichoupan K, Suprun M, Bagiella E, Dieterich DT, Perumalswami P, Branch AD, Huprikar S.

Clin Infect Dis. 2015 Dec 1;61(11):1742-8. doi: 10.1093/cid/civ654. Epub 2015 Aug 3.

37.

Hepatitis C virus infection and kidney transplantation: newer options and a brighter future ahead?

Del Bello D, Ross MJ, Huprikar SS.

Kidney Int. 2015 Aug;88(2):223-5. doi: 10.1038/ki.2015.180.

PMID:
26230200
38.

Liver transplantation for alveolar echinococcosis: Acceptable when necessary but is it preventable?

Hand J, Huprikar S.

Liver Transpl. 2015 Aug;21(8):1013-5. doi: 10.1002/lt.24197. No abstract available.

39.

Clinical characteristics of human immunodeficiency virus patients being referred for liver transplant evaluation: a descriptive cohort study.

Martel-Laferrière V, Michel A, Schaefer S, Bindal S, Bichoupan K, Branch AD, Huprikar S, Schiano TD, Perumalswami PV.

Transpl Infect Dis. 2015 Aug;17(4):527-35. doi: 10.1111/tid.12395. Epub 2015 Jun 15.

40.

Cryptococcosis in Patients With Cirrhosis of the Liver and Posttransplant Outcomes.

Singh N, Sifri CD, Silveira FP, Miller R, Gregg KS, Huprikar S, Lease ED, Zimmer A, Dummer JS, Spak CW, Koval C, Banach DB, Shroff M, Le J, Ostrander D, Avery R, Eid A, Razonable RR, Montero J, Blumberg E, Alynbiawi A, Morris MI, Randall HB, Alangaden G, Tessier J, Wagener MM, Sun HY.

Transplantation. 2015 Oct;99(10):2132-41. doi: 10.1097/TP.0000000000000690.

PMID:
25806406
41.

Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management.

Huprikar S, Danziger-Isakov L, Ahn J, Naugler S, Blumberg E, Avery RK, Koval C, Lease ED, Pillai A, Doucette KE, Levitsky J, Morris MI, Lu K, McDermott JK, Mone T, Orlowski JP, Dadhania DM, Abbott K, Horslen S, Laskin BL, Mougdil A, Venkat VL, Korenblat K, Kumar V, Grossi P, Bloom RD, Brown K, Kotton CN, Kumar D.

Am J Transplant. 2015 May;15(5):1162-72. doi: 10.1111/ajt.13187. Epub 2015 Feb 23.

42.

Donor-derived Strongyloides stercoralis infection in solid organ transplant recipients in the United States, 2009-2013.

Abanyie FA, Gray EB, Delli Carpini KW, Yanofsky A, McAuliffe I, Rana M, Chin-Hong PV, Barone CN, Davis JL, Montgomery SP, Huprikar S.

Am J Transplant. 2015 May;15(5):1369-75. doi: 10.1111/ajt.13137. Epub 2015 Feb 20.

43.

Hepatitis C and Human Immunodeficiency Virus Kidney Transplantation: The Mount Sinai Experience.

Nair V, Khaim R, El-Salem F, Kent R, Lerner S, Berger A, Miko L, Rollins B, Ebcioglu Z, Delaney V, Sehgal V, Menon M, Ames S, Benvenisty A, Wadhera V, Arvelakas A, Schiano T, Rana M, Huprikar S, Florman S, Shapiro R.

Clin Transpl. 2015;31:69-78.

PMID:
28514569
44.

Revisiting antifungal prophylaxis in high-risk liver transplant recipients.

Huprikar S.

Am J Transplant. 2014 Dec;14(12):2683-4. doi: 10.1111/ajt.12989. Epub 2014 Nov 6. No abstract available.

45.

Transmission of methicillin-resistant Staphylococcus aureus via deceased donor liver transplantation confirmed by whole genome sequencing.

Altman DR, Sebra R, Hand J, Attie O, Deikus G, Carpini KW, Patel G, Rana M, Arvelakis A, Grewal P, Dutta J, Rose H, Shopsin B, Daefler S, Schadt E, Kasarskis A, van Bakel H, Bashir A, Huprikar S.

Am J Transplant. 2014 Nov;14(11):2640-4. doi: 10.1111/ajt.12897. Epub 2014 Sep 22.

46.

Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression.

Sun HY, Alexander BD, Huprikar S, Forrest GN, Bruno D, Lyon GM, Wray D, Johnson LB, Sifri CD, Razonable RR, Morris MI, Stosor V, Wagener MM, Singh N.

Clin Infect Dis. 2015 Jan 1;60(1):36-44. doi: 10.1093/cid/ciu711. Epub 2014 Sep 9. Erratum in: Clin Infect Dis. 2016 Jun 15;62(12):1621.

47.

The role of secondary cytomegalovirus prophylaxis for kidney and liver transplant recipients.

Sullivan T, Brodginski A, Patel G, Huprikar S.

Transplantation. 2015 Apr;99(4):855-9. doi: 10.1097/TP.0000000000000386.

PMID:
25208322
48.

A pilot program to evaluate deceased donor disease transmission risk: the New York Organ Donor Network Infectious Disease Working Group.

Pellett Madan R, Delli Carpini K, Huprikar S, Lerner H, Patel G, Ratner LE, Goldstein MJ, Herold BC; New York Organ Donor Network Infectious Disease Working Group.

Transplantation. 2014 Oct 27;98(8):909-15. doi: 10.1097/TP.0000000000000152.

PMID:
24879385
49.

Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study.

Marukutira T, Huprikar S, Azie N, Quan SP, Meier-Kriesche HU, Horn DL.

HIV AIDS (Auckl). 2014 Mar 13;6:39-47. doi: 10.2147/HIV.S53910. eCollection 2014.

50.

Multidrug-resistant bacteria in organ transplantation: an emerging threat with limited therapeutic options.

Patel G, Rana MM, Huprikar S.

Curr Infect Dis Rep. 2013 Dec;15(6):504-13. doi: 10.1007/s11908-013-0371-z.

PMID:
24101302

Supplemental Content

Loading ...
Support Center